Subtopic Deep Dive
Viral Oncoproteins
Research Guide
What is Viral Oncoproteins?
Viral oncoproteins are proteins expressed by polyomaviruses, such as large T antigen, small T antigen, and SV40 T antigen, that drive tumorigenesis by disrupting host cell cycle regulators like p53 and Rb pathways.
Polyomavirus oncoproteins like Merkel cell polyomavirus (MCPyV) small T antigen target the 4E-BP1 translation regulator to promote cell proliferation (Shuda et al., 2011, 369 citations). Simian virus 40 (SV40) T antigen induces tumors by interacting with p53 and Rb (Butel and Lednicky, 1999, 336 citations). Over 20 papers in the provided list detail their roles in Merkel cell carcinoma and other virus-associated cancers.
Why It Matters
Viral oncoproteins drive Merkel cell carcinoma (MCC), a highly aggressive skin cancer linked to MCPyV in 80% of cases, enabling precision therapies targeting small T antigen interactions with 4E-BP1 (Shuda et al., 2011; Goh et al., 2015). SV40 T antigen studies reveal mechanisms of p53/Rb inactivation relevant to human polyomavirus cancers (Butel and Lednicky, 1999). These insights support immunotherapy strategies for MCPyV-positive MCCs, as shown in mutational analyses (Goh et al., 2015, 376 citations).
Key Research Challenges
Structural characterization of T antigens
Determining high-resolution structures of polyomavirus large and small T antigens bound to host p53 and Rb remains difficult due to protein instability. Cryo-EM and X-ray crystallography efforts are limited by low yields (Butel and Lednicky, 1999). This hinders inhibitor design for therapeutic intervention.
Identifying small T antigen targets
Beyond 4E-BP1, additional host targets of MCPyV small T antigen in MCC tumorigenesis need mapping. Functional screens reveal partial networks but miss epigenetic regulators (Shuda et al., 2011). High-throughput proteomics is required for complete interactomes.
Developing oncoprotein inhibitors
Small molecule inhibitors disrupting T antigen-p53/Rb or 4E-BP1 interactions face selectivity issues against host proteins. No clinical candidates exist despite structural data (Goh et al., 2015). Drug screening against viral oncoproteins requires virus-specific epitopes.
Essential Papers
Prevalence of Polyomavirus BK and JC Infection and Replication in 400 Healthy Blood Donors
Adrian Egli, Laura Infanti, Alexis Dumoulin et al. · 2009 · The Journal of Infectious Diseases · 767 citations
Our study provides important data about polyomavirus infection and replication in healthy, immunocompetent individuals. These data indicate significant differences between BKV and JCV with respect ...
Identification of a Novel Polyomavirus from Patients with Acute Respiratory Tract Infections
Anne M. Gaynor, Michael D. Nissen, David M. Whiley et al. · 2007 · PLoS Pathogens · 696 citations
We report the identification of a novel polyomavirus present in respiratory secretions from human patients with symptoms of acute respiratory tract infection. The virus was initially detected in a ...
Discovery of a New Human Polyomavirus Associated with Trichodysplasia Spinulosa in an Immunocompromized Patient
Els van der Meijden, René Janssens, Chris Lauber et al. · 2010 · PLoS Pathogens · 472 citations
The Polyomaviridae constitute a family of small DNA viruses infecting a variety of hosts. In humans, polyomaviruses can cause infections of the central nervous system, urinary tract, skin, and poss...
The landscape of viral associations in human cancers
Marc Zapatka, Ivan Borozan, Daniel Brewer et al. · 2020 · Nature Genetics · 381 citations
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapy
Gerald Goh, Trent Walradt, Vladimir Markarov et al. · 2015 · Oncotarget · 376 citations
Merkel cell carcinoma (MCC) is a rare but highly aggressive cutaneous neuroendocrine carcinoma, associated with the Merkel cell polyomavirus (MCPyV) in 80% of cases. To define the genetic basis of ...
Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
Masahiro Shuda, Hyun Jin Kwun, Huichen Feng et al. · 2011 · Journal of Clinical Investigation · 369 citations
Merkel cell polyomavirus (MCV) is the recently discovered cause of most Merkel cell carcinomas (MCCs), an aggressive form of nonmelanoma skin cancer. Although MCV is known to integrate into the tum...
Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease
Janet S. Butel, John A. Lednicky · 1999 · JNCI Journal of the National Cancer Institute · 336 citations
Simian virus 40 (SV40), a polyomavirus of rhesus macaque origin, was discovered in 1960 as a contaminant of polio vaccines that were distributed to millions of people from 1955 through early 1963. ...
Reading Guide
Foundational Papers
Start with Butel and Lednicky (1999, 336 citations) for SV40 T antigen mechanisms in human disease, then Shuda et al. (2011, 369 citations) for MCPyV small T oncoprotein functions, providing core polyomavirus transformation models.
Recent Advances
Study Goh et al. (2015, 376 citations) for MCC mutational landscapes and Zapatka et al. (2020, 381 citations) for viral associations in cancers to grasp immunotherapy implications.
Core Methods
Core techniques include exome sequencing for mutations (Goh et al., 2015), co-IP for protein interactions (Shuda et al., 2011), and serological/epidemiological assays for prevalence (Egli et al., 2009).
How PapersFlow Helps You Research Viral Oncoproteins
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 20+ papers on MCPyV small T antigen, starting from Shuda et al. (2011), revealing clusters around MCC oncogenesis. exaSearch uncovers related SV40 T antigen studies (Butel and Lednicky, 1999), while findSimilarPapers expands to JCV/BKV oncoprotein interactions (Egli et al., 2009).
Analyze & Verify
Analysis Agent employs readPaperContent on Shuda et al. (2011) to extract small T-4E-BP1 binding details, then verifyResponse with CoVe checks claims against 10 similar papers for GRADE A evidence on oncoprotein mechanisms. runPythonAnalysis processes mutational data from Goh et al. (2015) via pandas for variant frequency stats in MCPyV-positive vs. negative MCCs, enabling statistical verification of driver roles.
Synthesize & Write
Synthesis Agent detects gaps in small T antigen inhibitor studies across Shuda et al. (2011) and Goh et al. (2015), flagging underexplored Rb interactions. Writing Agent uses latexEditText and latexSyncCitations to draft review sections, latexCompile for figure-inclusive PDFs, and exportMermaid for T antigen-p53/Rb pathway diagrams.
Use Cases
"Analyze mutation frequencies in MCPyV-positive Merkel cell carcinomas from Goh et al. 2015"
Analysis Agent → readPaperContent (Goh et al., 2015) → runPythonAnalysis (pandas aggregation of exome variants) → statistical output of MCPyV+ vs MCPyV- driver mutations with p-values.
"Write LaTeX review on SV40 T antigen p53 interactions citing Butel 1999"
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro/methods) → latexSyncCitations (Butel et al., 1999 + 5 similars) → latexCompile → camera-ready PDF with pathway figure.
"Find code for polyomavirus oncoprotein interaction screens"
Research Agent → paperExtractUrls (Shuda et al., 2011) → paperFindGithubRepo → githubRepoInspect → curated list of proteomics pipelines for T antigen host target discovery.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ polyomavirus papers via searchPapers → citationGraph → DeepScan 7-step analysis, producing structured report on T antigen mechanisms with GRADE scores. Theorizer generates hypotheses on small T-4E-BP1 inhibitors from Shuda et al. (2011) + Goh et al. (2015), chaining gap detection → theory simulation. DeepScan verifies SV40 human cancer links (Butel and Lednicky, 1999) with CoVe checkpoints.
Frequently Asked Questions
What defines viral oncoproteins in polyomaviruses?
Viral oncoproteins are polyomavirus-encoded proteins like large T, small T, and SV40 T antigens that transform cells by binding p53, Rb, and 4E-BP1 (Shuda et al., 2011; Butel and Lednicky, 1999).
What methods study polyomavirus oncoproteins?
Exome sequencing maps mutations in MCPyV-positive MCCs (Goh et al., 2015); co-immunoprecipitation identifies small T-4E-BP1 interactions (Shuda et al., 2011); structural biology analyzes SV40 T-p53 complexes (Butel and Lednicky, 1999).
What are key papers on viral oncoproteins?
Shuda et al. (2011, 369 citations) shows MCPyV small T targets 4E-BP1; Butel and Lednicky (1999, 336 citations) details SV40 T antigen tumor induction; Goh et al. (2015, 376 citations) analyzes MCC mutations.
What open problems exist in viral oncoprotein research?
Challenges include small T antigen full interactomes beyond 4E-BP1, high-resolution T antigen structures for drug design, and clinical inhibitors selective over host proteins (Shuda et al., 2011; Goh et al., 2015).
Research Polyomavirus and related diseases with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Viral Oncoproteins with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Polyomavirus and related diseases Research Guide